
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | NASDAQ | USD | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZNCF | OTC Markets | USD | Delayed | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZN | London | GBP | Real-time | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Xetra | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Frankfurt | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.
Name | Age | Since | Title |
---|---|---|---|
Euan A. Ashley | 49 | 2020 | Independent Non-Executive Director |
Diana Layfield | 50 | 2020 | Independent Non-Executive Director |
Leif Johansson | 70 | 2012 | Independent Non-Executive Chairman |
Pascal Soriot | 62 | 2012 | CEO & Executive Director |
Philip Arthur John Broadley | 60 | 2017 | Senior Independent Non-Executive Director |
Katarina Ageborg | - | 2011 | EVP of Sustainability, Chief Compliance Officer & Member of External Sustainability Advisory Board |
Pam P. Cheng | 50 | 2015 | EVP of Operations & Information Technology and Member of External Sustainability Advisory Board |
Polly Courtice | 69 | - | Member of External Sustainability Advisory Board |
Rain Henderson | - | - | Member of External Sustainability Advisory Board |
Pankaj Bhatia | - | - | Member of External Sustainability Advisory Board |
Louise Nicholls | - | - | Member of External Sustainability Advisory Board |
Andreas Rummelt | 66 | 2021 | Independent Non-Executive Director |
Aradhana Sarin | 47 | 2021 | CFO & Executive Director |
Menelas Pangalos | - | 2013 | EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board |
Jeffrey Pott | - | 2009 | Chief Human Resources Officer, General Counsel & Member of External Sustainability Advisory Board |
Marcus Wallenberg | 66 | 1999 | Non-Executive Director |
Nazneen Rahman | 54 | 2017 | Independent Non-Executive Director |
Michel Demare | 66 | 2019 | Independent Non-Executive Director |
Sherilyn S. D. McCoy | 63 | 2017 | Independent Non-Executive Director |
Deborah DiSanzo Eldracher | 62 | 2017 | Independent Non-Executive Director |
Shu Kam Mok | 61 | 2019 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review